Mads Krogsgaard Thomsen

Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation, leads a vital discussion on Gefion, an AI supercomputer powered by Nvidia. He shares insights on its groundbreaking role in revolutionizing drug discovery and protein design. The conversation touches on how machine learning enhances research efficiency and accelerates therapy timelines. Mads also explores the supercomputer's diverse applications across biological research and agriculture while emphasizing the importance of equitable access to AI technologies for societal advancement.